INSIGHT is conducting international observational studies and international randomized trials on influenza.

FLU 002 Plus (Respiratory Virus Outpatient Study, INSIGHT Protocol No. 002) details on study

FLU 003 Plus (Respiratory Virus Hospitalization Study, INSIGHT Protocol No. 003) details on study

FLU-IVIG (Anti-Influenza Hyperimmune Intravenous Immunoglobulin Clinical Outcome Study, INSIGHT Protocol No. 006 ) details on study

CHIP is coordinating the FLU Plus studies in 6 European countries:
Belgium, Denmark, Estonia, Germany, Poland and Spain, and the FLU-IVIG study in Denmark and Spain.

For further details about the Influenza studies, please visit the INSIGHT website.